NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.

You can opt out at anytime by visiting our cookie policy page. In line with the provisions of the GDPR, the provision of your personal data is a requirement necessary to enter into a contract. We must advise you at the point of collecting your personal data that it is a required field, and the consequences of not providing the personal data is that we cannot provide this service to you.


Don't have an account? Subscribe

The Gander – 21 February 2019

By Mindo - 21st Feb 2019

Pat Kelly

The Medical Independent blog takes a look at the more unconventional niches in science and research

A newly-published study has highlighted a potential link between autoimmunity and microbiota in both clinical and pre-clinical disease, particularly in type 1 diabetes.

The authors suggest that gut microbiota, as well as human leukocyte antibody (HLA) genes, play a part in the disease and found a link between genetics and the human immune response and disturbances in the microbiome.

Studying 14 pools of bacteria and children with Crohn’s disease, type 1 diabetes and healthy controls, they discovered that serum from both the Crohn’s and diabetes patients had higher than usual levels of anticommensal antibodies. This suggested distinct patterns of immune response to gut microbiota. They concluded that the immune response in participants, as well as their genotype, predicted diagnosis.

Co-author Dr Christopher Yau of the University of Toronto, Canada, commented: “The interesting point about these risk genes is that they also play a central role in the ability of the immune system to recognise both proteins coming from foreign sources, such as bacteria and viruses, and proteins coming from the host body.”

The team hope to extend their work to look for biomarkers  in other diseases, such as rheumatoid arthritis and multiple sclerosis.

The research was published recently in Science Immunology.

Leave a Reply

Latest
Latest Issue
The Medical Independent 20th February
The Medical Independent 20th February 2024

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read